Klysz D, Tai X, Robert PA, Craveiro M, Cretenet G, Oburoglu L, et al
Elevated heart rate from both medications stacking together is the primary risk clinicians worry about
The author declares that they have no competing interests
Established clinical use Not established by this product page or its analytical documents
[10] [11] It's important to understand that GLP-1 medications are initiated at a low dose and gradually increased over several weeks to minimise gastrointestinal side effects such as nausea and vomiting
Another recent screening identified that H3K9 demethylation-mediated upregulation of BCAT1 and subsequent BCAA metabolic reprogramming is able to enhance the capacity for sublethal epidermal growth factor receptor (EGFR) inhibitor (TKI) resistance by producing ROS scavengers in lung cancer, which is a cancer where EGFR mutations are commonly found (Wang et al., 2019b)